Ballicules.com

Oxazepam

SERAX

What it isGABA-A-positive benzodiazepine; anxiety and alcohol withdrawal.

Why it mattersIts slow absorption lowers abuse appeal, while direct glucuronidation makes it more predictable than diazepam in liver disease.

What it changesSedation and falls can end treatment; opioids magnify respiratory depression, and abrupt withdrawal can provoke seizures.

FDA-approved for

FDA label

BOXED WARNING Concomitant use with opioids (profound sedation, respiratory depression, coma, death); abuse, misuse, addiction; dependence and withdrawal reactions
FDA dosingPopulationStartTargetMax
Mild-moderate anxietyAdults10-15 mg TID-QID10-15 mg TID-QID
Severe anxiety syndromes / anxiety with depressionAdults15-30 mg TID-QID15-30 mg TID-QID
Anxiety in older patientsElderly10 mg TIDincrease cautiously to 15 mg TID-QID
Alcohol withdrawal (acute inebriation/tremulousness)Adults15-30 mg TID-QID15-30 mg TID-QID

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy Undefined

Lactation Undefined

⚠ BOXED WARNINGS

Cost, est. cash$10–$300/month

Generic entry1987

Classes and tags

Clinical profile

Therapeutic safety burden2 / 4
Overdose danger2 / 4
Weight-gain liability0 / 4
Sedation liability2 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryD

Defining liabilitySedation, falls, dependence and additive respiratory depression with opioids or other CNS depressants.

Mechanism of action: Oxazepam ballicule

Oxazepam ballicule: receptor binding, kinetics and half-life diagram

Open Oxazepam in the interactive console ↗

Memory aids: mascots and interaction avatars

Oxazepam SERAX mascot mnemonic cartoon
“Sera axed Ox”
Oxazepam UGT2B15 substrate avatar
UGT2B15 substrate

Open Oxazepam in the interactive console ↗